| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |